Loading patent…
AssigneesShimadzu Corporation, Tokyo Electron Limited
InventorsTakashi SUZUKI, Kenichi TOYODA, Masatoshi TAKAHASHI, Keisuke HARA, Tomohisa NAGATA, Yasuhiro OSHIMA
Estimating the term…
Disclosed is a method for evaluating if there are genomic abnormalities in cells being tested, the cells being tested being pluripotent stem cells cultivated in a culture medium or cells resulting from the induced differentiation of pluripotent stem cells, the method including a step of measuring the amount of an indicator present in the culture supernatant of the test cells, and a step of evaluating, on the basis of the amount of the indicator present, if there are genomic abnormalities in the test cells, wherein the indicator is at least one selected from the group consisting of deoxycytidine, kynurenine, putrescine, alanine, cysteine, cystathionine, and threonic acid, and whether or not there are genomic abnormalities in the test cells is evaluated on the basis of the amount of the at least one indicator present.
An evaluation method for genomic abnormalities, wherein it is evaluated whether test cells have genomic abnormalities using pluripotent stem cells cultured in a culture medium or cells induced to differentiate from pluripotent stem cells as the test cells, the method comprising:
Dependencies are inferred from the claim text.